Zdravlje is pleased to announce an important expansion of our commercial capabilities in Serbia. As of 10 January, Zdravlje has added five medical representatives who will be working directly with doctors and pharmacists to provide professional support, expertise and information on our high quality product portfolio.

Zdravlje is pleased to announce that as of 1 January 2022, Mr. Semir Attar has joined our senior management team as Director of Regulatory & Public Affairs, directly reporting to Kiren Naidoo (CEO).

Zdravlje Leskovac continues its several-years’ activity aimed to support persons with disabilities as a partner to the "Cap for Handicap" Association.

Zdravlje is pleased to announce that as of 1st November 2021, Dragana Mirkovic has joined our team as a Product Manager. Dragana will report directly to Dragan Cirkovic, Commercial Director.

Approximately six months into new ownership Zdravlje A.D. (“Zdravlje”) is proud to announce the signing of a new agreement with Celltrion Healthcare Hungary Kft. (“Celltrion Healthcare”), a leading force in the biopharmaceutical industry. This agreement will make regdanvimab (CT-P59), a monoclonal antibody treatment for COVID-19, available for patients in Serbia and in the ex-Yugoslavia region.

Zdravlje is pleased to announce that as of 11 October 2021, Ana Kostadinovic has joined our team in Belgrade as Office Manager, directly reporting to Chief Executive Officer Kiren Naidoo.

Zdravlje is pleased to announce that as of 1 October 2021, Jelena Jovanovic has joined our Commercial team in Belgrade as Key Account Manager, directly reporting to Dragan Cirkovic, Commercial Director.

Under new ownership, Zdravlje announces an expansion of its international presence to improve the availability of its high quality products worldwide.

Zdravlje is pleased to announce that as of 15th September 2021, Dusan Drenic has joined our team as a Sales Manager. Dusan will report directly to Dragan Cirkovic, Commercial Director.